Dr. Patricia Young specializes in hematology and medical oncology with an emphasis in clinical and translational research. She is a member of the UCLA Bone Marrow Transplant and Cellular Therapy team, and conducts clinical trials in the Hematologic Malignancies Program and the Lymphoma Program. She has also worked with the UCLA Thoracic Oncology Program studying the effects of estrogens in non-small cell lung cancer.
Young P, Kim B, Malin JL. Preoperative breast MRI in early-stage breast cancer. Breast Cancer Research and Treatment, Oct; 135(3): 907-12, 2012. PMID 22923237
Young PA, Morrison SL, Timmerman JM. Antibody-Cytokine Fusion Proteins for Treatment of Cancer: Engineering Cytokines for Improved Efficacy and Safety. Seminars in Oncology Oct; 41(5): 623-36, 2014. PMID: 25440607
Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Parikh RJ, Patel R, Hu EH, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang H, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer, 2018. 123: p. 91-98. PMID: 30089602
Young PA, Yamada RE, Trinh DR, Vasuthasawat A, De Oliveira S, Yamada DH, Morrison SL, Timmerman JM. Activity of anti-CD19 CAR T cells against B cell lymphoma is enhanced by antibody-targeted interferon-alpha. Journal of Interferon & Cytokine Research, 2018 Jun;38(6):239-254. PMID: 29920129
Young PA, Gaut D, Kimaiyo DK, Grotts J, Chute JP, Schiller GJ, de Vos S, Eradat HA, Timmerman JM. Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32229199